Note sull'episodio
The introduction of kinase inhibitors has significantly impacted the treatment landscape of plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1). In this podcast activity from the 2025 Annual Oncology Meeting, noteworthy data in NF1-PN has been summarized and evaluated by Dr. Amy Armstrong. This activity is AMA/ABS/ANCC/ACPE accredited for one-year.
Launch Date: June 5, 2025
Release Date: June 5, 2025
Expiration Date: May 31, 2026
FACULTY
Amy Armstrong, MD
Assistant Professor of Pediatrics
Division of Hematology/Oncology
Neurofibromatosis (NF) Center
Washington University School of Medicine
St. Louis, Missouri
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditat ...